IP Library Granted Patent US 7,807,386
Granted Patent B2
US 7,807,386 · App. 12/357,888 · Granted Oct 5, 2010

Peptides for discrimination of prions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,807,386
App. No.
12/357,888
Granted
Oct 5, 2010
Kind
B2
Abstract

The aim of the present invention is to provide a non-intrusive way to isolate, concentrate and monitor the TSE disease-related pathogenic prion protein. The invention described several peptides and their ability to capture PrP Sc from brain homogenate of prion disease infected animal and human. These eight peptides do not capture cellular prion protein from individual with no prion disease.

Claims (18)

1. A method for detection of PrP Sc comprising:

first contacting a sample with a peptide consisting of an amino acid sequence selected from the group consisting of: SEQ ID NO:1: WQPPRARI; SEQ ID NO:2: NWCKRGRKQCKTH; SEQ ID NO:3: NYKKPKL; SEQ ID NO:5: YRGYRGYRGYRG; SEQ ID NO:6: YRGRYGYKGKYGYRG; SEQ ID NO:7: AQKKDGKKRKRSRKESYSIYV; SEQ ID NO:8: ARTKQTARKSTGGKSPRKQLA; and SEQ ID NO:9: SGRGKGGKGLGKGGAKRHRKVLR; and

then detecting PrP Sc with a labeled prion specific antibody, wherein the peptide specifically captures PrP Sc and the labeled prion specific antibody detects the captured PrP Sc .

2. A method for detection of PrP Sc comprising:

first contacting a sample with a prion specific antibody; and

then detecting PrP Sc with a labeled peptide consisting of an amino acid sequence selected from the group consisting of: SEQ ID NO:1: WQPPRARI; SEQ ID NO:2: NWCKRGRKQCKTH; SEQ ID NO:3: NYKKPKL; SEQ ID NO:5: YRGYRGYRGYRG; SEQ ID NO:6: YRGRYGYKGKYGYRG; SEQ ID NO:7: AQKKDGKKRKRSRKESYSIYV; SEQ ID NO:8: ARTKQTARKSTGGKSPRKQLA; and SEQ ID NO:9: SGRGKGGKGLGKGGAKRHRKVLR; wherein the prion specific antibody captures PrP C and PrP Sc and the labeled peptide specifically detects the captured PrP Sc .

3. An immunoassay for detecting PrP Sc comprising:

providing a solid support having bound thereto a peptide consisting of an amino acid sequence selected from the group consisting of: SEQ ID NO:1: WQPPRARI; SEQ ID NO:2: NWCKRGRKQCKTH; SEQ ID NO:3: NYKKPKL; SEQ ID NO:5: YRGYRGYRGYRG; SEQ ID NO:6: YRGRYGYKGKYGYRG; SEQ ID NO:7: AQKKDGKKRKRSRKESYSIYV; SEQ ID NO:8: ARTKQTARKSTGGKSPRKQLA; and SEQ ID NO:9: SGRGKGGKGLGKGGAKRHRKVLR;

contacting the solid support with a sample;

washing the support to remove any unbound sample;

contacting the solid support with a labeled prion specific antibody; and

carrying out a detection step to determine if PrP Sc are bound to the solid support, wherein the peptide specifically captures PrP Sc and the labeled prion specific antibody detects the captured PrP Sc .

4. An immunoassay for detecting PrP Sc comprising:

providing a solid support having bound thereto a prion specific antibody;

contacting the solid support with a sample;

washing the support to remove any unbound sample;

contacting the solid support with a labeled peptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NO:1: WQPPRARI; SEQ ID NO:2: NWCKRGRKQCKTH; SEQ ID NO:3: NYKKPKL; SEQ ID NO:5: YRGYRGYRGYRG; SEQ ID NO:6: YRGRYGYKGKYGYRG; SEQ ID NO:7: AQKKDGKKRKRSRKESYSIYV; SEQ ID NO:8: ARTKQTARKSTGGKSPRKQLA; and SEQ ID NO:9: SGRGKGGKGLGKGGAKRHRKVLR; and

carrying out a detection step to determine if PrP Sc are bound to the solid support, wherein the prison specific antibody captures PrP C and PrP Sc and the labeled peptide specifically detects the captured PrP Sc .

Assignments (5)
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
Reel/Frame 060219/0571 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2018
From: ZHENG, JIAN
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 045916/0580 →
SECURITY INTEREST Recorded Jul 3, 2014
From: ORTHO-CLINICAL DIAGNOSTICS, INC; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 033276/0104 →